Information Provided By: 
Fly News Breaks for June 27, 2016
ZLTQ
Jun 27, 2016 | 10:35 EDT
Piper Jaffray analyst Matt O'Brien noted that the timing of the commercial launch of the new CoolAdvantage applicator from Zeltiq, while late in the quarter, will allow the company to recognize some CoolAdvantage revenue in Q2, which is important given concerns it was going to get pushed out. The analyst, who said the applicators carry multiple benefits for both the patient and physician, keeps an Overweight rating and $40 price target on ZELTIQ shares.
News For ZLTQ From the Last 2 Days
There are no results for your query ZLTQ
